We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity

    Lung squamous cell carcinoma (LUSC) is associated with high mortality and limited targeted therapies. USP13 is one of the most amplified genes in...

    Juntae Kwon, **min Zhang, ... Cecil Han in Molecular Cancer
    Article Open access 13 December 2023
  2. The insufficiency of CT examination in early detection of central lung squamous cell carcinoma and squamous epithelial precancerous lesions

    Background

    CT examination for lung cancer has been carried out for more than 20 years and great achievements have been made in the early detection of...

    Jiaming Zhou, Bijun Yu, ... Shi Wang in BMC Cancer
    Article Open access 05 March 2024
  3. Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma

    Objective

    The optimal timing for surgery following neoadjuvant immunochemotherapy for lung squamous cell carcinoma appears to be a topic of limited...

    Chen Gu, **ao Teng, ... **ayi Lyu in BMC Cancer
    Article Open access 13 May 2024
  4. Bioinformatics Identification and Experimental Validation of a Prognostic Model for the Survival of Lung Squamous Cell Carcinoma Patients

    Lung squamous cell carcinoma (LUSC) kills more than four million people yearly. Creating more trustworthy tumor molecular markers for LUSC early...

    Hongtao Zhao, Ruonan Sun, ... Juan Du in Biochemical Genetics
    Article 28 May 2024
  5. Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma

    Background

    Squamous cell carcinoma (SqCC) is a subtype of non-small cell lung cancer for which patient prognosis remains poor. The extracellular...

    Amelia L. Parker, Elise Bowman, ... Thomas R. Cox in Genome Medicine
    Article Open access 21 November 2022
  6. Tenascin C as a novel zinc finger protein 750 target regulating the immunogenicity via DNA damage in lung squamous cell carcinoma

    Modulation of DNA damage repair in lung squamous cell carcinoma (LUSC) can result in the generation of neoantigens and heightened immunogenicity....

    Lu **a, Hexin Lin, ... Jiabian Lian in BMC Cancer
    Article Open access 06 May 2024
  7. MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3

    In contrast to the decreasing trends in developed countries, the incidence and mortality rates of cervical squamous cell carcinoma in China have...

    Aiqin Zhao, Yunzhi Pan, ... Sai Ma in BMC Cancer
    Article Open access 03 May 2024
  8. OCT4’s role and mechanism underlying oral squamous cell carcinoma

    Oral squamous cell carcinoma (OSCC), a common malignancy of the head and neck, ranks sixth worldwide in terms of cancers with the most negative...

    Yuwei Dai, Ziqiong Wu, ... Huiyong Zhu in Journal of Zhejiang University-SCIENCE B
    Article 27 September 2023
  9. Advances in cutaneous squamous cell carcinoma

    Human malignancies arise predominantly in tissues of epithelial origin, where the stepwise transformation from healthy epithelium to premalignant...

    Mårten C. G. Winge, Laura N. Kellman, ... Paul A. Khavari in Nature Reviews Cancer
    Article 07 June 2023
  10. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example

    Compared with those in adenocarcinoma, PIK3CA mutations are more common in squamous cell carcinoma (SCC), which arises from stratified squamous...

    Shutao Zheng, Shuo He, ... **aomei Lu in Molecular Biomedicine
    Article Open access 15 April 2024
  11. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach

    Relevance

    The proteasome is a crucial mechanism that regulates protein fate and eliminates misfolded proteins, playing a significant role in cellular...

    **gru Yang, Serge Yannick Ouedraogo, ... **anquan Zhan in EPMA Journal
    Article 04 March 2024
  12. Reciprocal FGF19-GLI2 signaling induces epithelial-to-mesenchymal transition to promote lung squamous cell carcinoma metastasis

    Purpose

    Metastatic lung squamous cell carcinoma (LUSC) is one of the most common causes of cancer death worldwide. As yet, however, the molecular...

    Yanshuang Zhang, Tingyu Wu, ... Weiliang **a in Cellular Oncology
    Article 04 January 2023
  13. Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: a systematic review

    Background

    There are differences in the pharmacoeconomics of Immune checkpoint blocking (ICB) therapies for the treatment of lung squamous cell...

    Minyu Cheng, Yanfei Shao, ... Zhouye Song in BMC Cancer
    Article Open access 06 March 2024
  14. Biomedical Approaches in the Research and Management of Head and Neck Squamous Cell Carcinoma

    This chapter discusses emerging novel approaches for the molecular characterization of head and neck squamous cell carcinoma (HNSCC). The chapter...
    Chapter 2024
  15. Preclinical models in head and neck squamous cell carcinoma

    Head and neck cancer is the sixth most frequent cancer type. Drug resistance and toxicity are common challenges of the existing therapies, making the...

    Patricia Chaves, María Garrido, ... Antonio Rueda-Domínguez in British Journal of Cancer
    Article Open access 10 February 2023
  16. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma

    Background

    N7-Methylguanosine (m7G) and long non-coding RNAs (lncRNAs) have been widely studied in cancer and have been found to be useful for...

    Junfan Pan, Zhidong Huang, ... Jiancheng Li in BMC Cancer
    Article Open access 04 November 2022
  17. RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma

    Objectives

    RAD51 overexpression has been reported to serve as a marker of poor prognosis in several cancer types. This study aimed to survey the role...

    Yu-Fen Tsai, Leong-Perng Chan, ... Shyng-Shiou F. Yuan in Cancer Cell International
    Article Open access 05 October 2023
  18. Survival-associated N6-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification

    Background

    N 6 -methyladenine (m 6 A) is the most common modification of mRNA and IncRNA in higher organisms. m 6 A has been confirmed to be related to the...

    Jialin Qu, Li Wang, ... **aochun Zhang in BMC Cancer
    Article Open access 24 November 2021
  19. Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study

    Background

    Despite major advances in cancer therapeutics, the therapeutic options of Lung Squamous Cell Carcinoma (LSCC)-specific remain limited....

    Chen-ye Shao, **g Luo, ... Li-qin Yang in BMC Cancer
    Article Open access 29 September 2023
  20. Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1

    Background

    While radiation therapy remains pivotal in esophageal squamous cell carcinoma (ESCC) treatment, the perplexing phenomenon of post-radiation...

    Shan Huang, Jiayi Zhang, ... Fang Li in BMC Cancer
    Article Open access 03 May 2024
Did you find what you were looking for? Share feedback.